If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. Return both documents to the BEACON-Neuroblastoma Trial Office.

• UK Investigator Registration Form [.pdf 200KB]

• UK Site Staff Registration Form [.pdf 255KB]

• Site Signature Delegation Log v2.0 [pdf 155KB]

• International Site Staff Database Access Update v4.0 [.pdf 355KB]

Links to the current protocol, Patient Information Sheet and Informed Consent Form are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below.

If you cannot find what you are looking for please email the BEACON-Neuroblastoma Trials Office.

• BEACON Protocol v7.0 07Feb2020 [pdf 5526KB]

• BEACON PIS (Parent) v9.0 05Feb2020 [pdf 1304KB]

• BEACON PIS (Over 16) v9.0 05Feb2020 [pdf 571KB]

• BEACON PIS (13- 15 years) v7.0 vd05Feb2020 [pdf 480KB]

• BEACON PIS (8-12 years) v7.0 vd05Feb2020 [pdf 278KB]

• BEACON PIS under 8 years of age v3.0 vd05Feb2020 [pdf 323KB]

• BEACON Informed Consent Form(Parent) v7.0b vd03Oct2019 [pdf 912KB]

• BEACON Informed Consent Form(Over 16) v7.0 vd01Nov2018 [pdf 277KB]

• BEACON PIS and ICF Addendum B [pdf 790KB]

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control Log. A link to the Version Control List used in this trial is below.

• BEACON Version Control List v30.0 vd24Aug2022 [pdf 269KB]

Amendments

Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

• BEACON Amendment SA21 [opens new page]

• BEACON Amendment SA18-19 [opens new page]

• BEACON Amendment SA-11/12 [opens new page]

• BEACON Amendment SA-06 [opens new page]

• BEACON Amendment SA-05 [opens new page]

• BEACON Amendment SA-04 [opens new page]

• BEACON Amendment SA-03  [opens new page]

• BEACON Amendment SA-02 (1) [opens new page]

Case Report Form

• BEACON Case Report Forms (current) [pdf 7371KB]

Guidelines

• BEACON CRF Completion Guidelines v5.0 [pdf 169KB]

• BEACON SAE & Expected SAR Form Completion Guidelines v4.0 [pdf 228KB]

• Setting up your password for the BEACON database v2.0 [pdf 237KB]

Other Trial Documents

• BEACON Pharmacy Manual v6.0 [pdf 707KB]

• BEACON Pharmacy Manual GD2 v2.0 [pdf 803KB]

• Newsletter Oct 2016 [.pdf 2.85MB]

• Newsletter Dec 2015 [.pdf 670KB]

• Newsletter Jul 2015 [.pdf 821KB]

• Newsletter Feb-2015 [.pdf 826KB]

• Newsletter Jun-2018 [.pdf 797KB]

• Newsletter Mar-2019 [.pdf 638KB]

• Newsletter Jan- 2020 [.pdf 842KB]

• Newsletter Jun- 2020 [.pdf 864KB]

• Newsletter Feb- 2021 [.pdf 1152KB]

• BEACON Poster featured at ASCO 2015 [.pdf 926KB]

• BEACON Novel Statistical protocol featured at SIOP 2015 [.pdf 699KB]

Chief Investigator

Dr Lucas Moreno                                                                                  

Cancer Research UK Consultant in Paediatric Oncology

Cancer Research UK Clinical Trials Unit (CRCTU)
School of Cancer Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Tel: +44 (0) 121 414 3788 

Email: lucas.moreno@vallhebron.cat 

Beacon Trial Office

Trial Coordinator:  Bethany Logan
Trial Monitor:   Shaneed Hajee
Trial Management Team Leader:  Charlotte Firth
Trial Statistician: Rebekah Weston

Cancer Research UK Clinical Trials Unit (CRCTU)
School of Cancer Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Enquiries

Telephone: +44 (0) 121 414 3788 
Fax: +44 (0) 121 414 9520
Email: beacon@trials.bham.ac.uk

Trial Entry

Recruitment to the BEACON-Neuroblastoma trial is now closed.

Serious Adverse Event Reporting

SAE's should be emailed to the BEACON-Neuroblastoma Trial Office, CRCTU, University of Birmingham, UK

reg@trials.bham.ac.uk

Sponsor

University of Birmingham

CRCTU Home Page

http://www.birmingham.ac.uk/crctu